-
EP1545517
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1545517
| EP1545517 - OXAZOLIDIN-2-ONE AND THIAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF GLAUCOMA [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 25.05.2007 Database last updated on 09.09.2024 | Most recent event Tooltip | 25.05.2007 | Application deemed to be withdrawn | published on 27.06.2007 [2007/26] | Applicant(s) | For all designated states Merck Frosst Canada Ltd. 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | [2006/40] |
| Former [2005/26] | For all designated states MERCK FROSST CANADA & CO. 16711 Trans-Canada Highway Kirkland, Quebec H9H 3L1 / CA | Inventor(s) | 01 /
HAN, Yongxin 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 02 /
COLUCCI, John 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 03 /
BILLOT, Xavier 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 04 /
WILSON, Marie-Claire 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | 05 /
YOUNG, Robert 16711 Trans-Canada Highway Kirkland, Québec H9H 3L1 / CA | [2005/26] | Representative(s) | Buchan, Gavin MacNicol, et al Merck Sharp & Dohme Limited European Patent Department Hertford Road Hoddesdon Hertfordshire EN11 9BU / GB | [N/P] |
| Former [2006/48] | Buchan, Gavin MacNicol, et al Merck & Co., Inc. European Patent Department Merck Sharp & Dohme Limited, Hertford Road, Hoddesdon Hertfordshire, EN11 9BU / GB | ||
| Former [2005/26] | Buchan, Gavin MacNicol Merck & Co., Inc., European Patent Department, Terlings Park, Eastwick Road Harlow, Essex CM20 2QR / GB | Application number, filing date | 03790594.0 | 25.08.2003 | [2005/26] | WO2003CA01306 | Priority number, date | US20020406530P | 28.08.2002 Original published format: US 406530 P | [2005/26] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004019938 | Date: | 11.03.2004 | Language: | EN | [2004/11] | Type: | A1 Application with search report | No.: | EP1545517 | Date: | 29.06.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.03.2004 takes the place of the publication of the European patent application. | [2005/26] | Search report(s) | International search report - published on: | EP | 11.03.2004 | Classification | IPC: | A61K31/422, A61K31/427, A61P27/06, C07D277/14, C07D417/06, C07D417/14, C07D263/24, C07D413/06, C07D413/14 | [2005/26] | CPC: |
C07D263/20 (EP,US);
A61P27/02 (EP);
A61P27/06 (EP);
A61P43/00 (EP);
C07D263/24 (EP,US);
C07D277/14 (EP,US);
C07D413/06 (EP,US);
C07D413/10 (EP,US);
C07D413/14 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/26] | Extension states | AL | Not yet paid | LT | 29.03.2005 | LV | 29.03.2005 | MK | Not yet paid | Title | German: | OXAZOLIDIN-2-ON UND THIAZOLIDIN-2-ON-DERIVATE ZUR VERWENDUNG ALS EP4-REZEPTOR-AGONISTEN BEI DER BEHANDLUNG VON GLAUKOM | [2005/26] | English: | OXAZOLIDIN-2-ONE AND THIAZOLIDIN-2-ONE DERIVATIVES FOR USE AS EP4 RECEPTOR AGONISTS IN THE TREATMENT OF GLAUCOMA | [2005/26] | French: | DERIVES DE L'OXAZOLIDIN-2-ONE ET DE LA THIAZOLIDIN-2-ONE ANTAGONISTES DU RECEPTEUR EP4, POUR LE TRAITEMENT DU GLAUCOME | [2005/26] | Entry into regional phase | 29.03.2005 | National basic fee paid | 29.03.2005 | Designation fee(s) paid | 29.03.2005 | Examination fee paid | Examination procedure | 11.03.2004 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 29.03.2005 | Examination requested [2005/26] | 21.08.2006 | Despatch of a communication from the examining division (Time limit: M04) | 03.01.2007 | Application deemed to be withdrawn, date of legal effect [2007/26] | 02.02.2007 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2007/26] | Fees paid | Renewal fee | 08.08.2005 | Renewal fee patent year 03 | 07.08.2006 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [PX]WO03009872 (ONO PHARMACEUTICAL CO [JP], et al) [PX] 1-15 * examples 3(ff), 3(gg), 3(hh);; claim 12 *; | [E]WO03074483 (ONO PHARMACEUTICAL CO [JP], et al) [E] 1-15 * claim 1 *; | [A]JPS58150575 | [A] - PATENT ABSTRACTS OF JAPAN, (19831130), vol. 007, no. 268, Database accession no. (C - 197), & JP58150575 A 19830907 (CHUGAI SEIYAKU KK) [A] 1-15 * Formula I * |